Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00219440 · ClinicalTrials.gov registry record · Phase 4
A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS
A Phase 4 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00219440 is a Phase 4 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 60 participants.
The verdict
NCT00219440, a Phase 4 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
We hypothesized that a portion controlled diet would prevent the weight gain associated with the use of a peroxisome profliferator-activated receptor-gamma (PPAR-g). This is a 4 months randomized clinical trial in type 2 diabetics who are treated with pioglitazone and a standard diet, pioglitazone and a portion-controlled diet and metformin with a standard diet.
Interventions
- OTHER Actos plus standard diet
- OTHER Actos plus structured diet
- OTHER Metformin plus standard diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2003-02 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00219440
The ClinicalTrials.gov registry entry for NCT00219440 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Actos plus standard diet is the first listed.
NCT00219440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00219440 about?
NCT00219440 is a clinical study titled "A Portion-controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS". We hypothesized that a portion controlled diet would prevent the weight gain associated with the use of a peroxisome profliferator-activated receptor-gamma (PPAR-g). This is a 4 months randomized clinical trial in type 2 diabetics who are treated with pioglitazone and a standard diet, pioglitazone a...
What is the current status of trial NCT00219440?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2003-02. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00219440?
The interventions under investigation include: Actos plus standard diet (OTHER), Actos plus structured diet (OTHER), Metformin plus standard diet (OTHER).
Who is sponsoring clinical trial NCT00219440?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.